Clinical trial
Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to…
NCT00072098 · Max Sung, Other · Terminated
Key facts
| NCT number | NCT00072098 |
|---|---|
| Title | Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer |
| Official title | Phase I Trial Of Adenoviral Vector Delivery Of The Human Interleukin-12 cDNA By Intratumoral Injection In Patients With Metastatic Colorectal Cancer To The Liver |
| Lead sponsor | Max Sung, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | adenovirus vector, interleukin-12 gene |
| Enrollment | 22 |
| Start date | Sep 1, 2003 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Nov 6, 2003 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: